Terms: = Bone cancer AND CUX1, ENSG00000160967, P39880, p75, p200, p110, p100, Nbla10317, CUX, COY1, CDP, CASP, 1523 AND Diagnosis
19 results:
1. Adolescents and young adults with rhabdomyosarcoma treated in the European paediatric Soft tissue sarcoma Study Group (EpSSG) protocols: a cohort study.
Ferrari A; Chisholm JC; Jenney M; Minard-Colin V; Orbach D; Casanova M; Guillen G; Glosli H; van Rijn RR; Schoot RA; Cameron AL; Rogers T; Alaggio R; Ben-Arush M; Mandeville HC; Devalck C; Defachelles AS; Coppadoro B; Bisogno G; Merks JHM
Lancet Child Adolesc Health; 2022 Aug; 6(8):545-554. PubMed ID: 35690071
[TBL] [Abstract] [Full Text] [Related]
2. Reforming support systems of newly diagnosed brain cancer patients: a systematic review.
Loizidou M; Sefcikova V; Ekert JO; Bone M; Samandouras G
J Neurooncol; 2022 Jan; 156(1):61-71. PubMed ID: 34826034
[TBL] [Abstract] [Full Text] [Related]
3. A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes.
Nazha A; Hu ZH; Wang T; Lindsley RC; Abdel-Azim H; Aljurf M; Bacher U; Bashey A; Cahn JY; Cerny J; Copelan E; DeFilipp Z; Diaz MA; Farhadfar N; Gadalla SM; Gale RP; George B; Gergis U; Grunwald MR; Hamilton B; Hashmi S; Hildebrandt GC; Inamoto Y; Kalaycio M; Kamble RT; Kharfan-Dabaja MA; Lazarus HM; Liesveld JL; Litzow MR; Majhail NS; Murthy HS; Nathan S; Nishihori T; Pawarode A; Rizzieri D; Sabloff M; Savani BN; Schachter L; Schouten HC; Seo S; Shah NN; Solh M; Valcárcel D; Vij R; Warlick E; Wirk B; Wood WA; Yared JA; Alyea E; Popat U; Sobecks RM; Scott BL; Nakamura R; Saber W
Biol Blood Marrow Transplant; 2020 Nov; 26(11):2139-2146. PubMed ID: 32781289
[TBL] [Abstract] [Full Text] [Related]
4. The Role of O
Zhang W; Liu M; Li Y; Song S; Li K; Ma Y
Pathol Oncol Res; 2020 Apr; 26(2):1201-1209. PubMed ID: 31190217
[TBL] [Abstract] [Full Text] [Related]
5. Skull Base Juvenile Psammomatoid Ossifying Fibroma: Clinical Characteristics, Treatment, and Prognosis.
Wang K; Ma XJ; Hao SY; Du J; Zhang LW; Zhang JT; Wu Z
World Neurosurg; 2019 May; 125():e843-e848. PubMed ID: 30743026
[TBL] [Abstract] [Full Text] [Related]
6. p75 neurotrophin receptor expression in squamous cell carcinoma.
Anolik RB; Aung PP; Bhawan J
Am J Dermatopathol; 2015 Feb; 37(2):160-1. PubMed ID: 25321086
[TBL] [Abstract] [Full Text] [Related]
7. Brain metastases from thyroid carcinoma: a retrospective study of 21 patients.
Henriques de Figueiredo B; Godbert Y; Soubeyran I; Carrat X; Lagarde P; Cazeau AL; Italiano A; Sargos P; Kantor G; Loiseau H; Bonichon F
Thyroid; 2014 Feb; 24(2):270-6. PubMed ID: 23734630
[TBL] [Abstract] [Full Text] [Related]
8. cancer diagnostics: decision criteria for marker utilization in the clinic.
Taube SE; Jacobson JW; Lively TG
Am J Pharmacogenomics; 2005; 5(6):357-64. PubMed ID: 16336001
[TBL] [Abstract] [Full Text] [Related]
9. [Co-expression of TrkA and p75 neurotrophin receptor in extracranial olfactory neuroblastoma cells].
Zhao SP
Hunan Yi Ke Da Xue Xue Bao; 2003 Feb; 28(1):50-2. PubMed ID: 12934398
[TBL] [Abstract] [Full Text] [Related]
10. Molecular heterogeneity in human osteosarcoma demonstrated by enriched mRNAs isolated by directional tag PCR subtraction cloning.
Olstad OK; Gautvik VT; Reppe S; Rian E; Jemtland R; Ohlsson C; Bruland OS; Gautvik KM
Anticancer Res; 2003; 23(3B):2201-16. PubMed ID: 12894494
[TBL] [Abstract] [Full Text] [Related]
11. Co-expression of trkA and p75 neurotrophin receptor in extracranial olfactory neuroblastoma cells.
Zhao SP; Zhou XF
Neuropathol Appl Neurobiol; 2002 Aug; 28(4):301-7. PubMed ID: 12175342
[TBL] [Abstract] [Full Text] [Related]
12. Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocol.
Bacci G; Briccoli A; Ferrari S; Longhi A; Mercuri M; Capanna R; Donati D; Lari S; Forni C; DePaolis M
Eur J Cancer; 2001 Nov; 37(16):2030-9. PubMed ID: 11597381
[TBL] [Abstract] [Full Text] [Related]
13. Upregulation of casp genes in human tumor cells undergoing etoposide-induced apoptosis.
Droin N; Dubrez L; Eymin B; Renvoizé C; Bréard J; Dimanche-Boitrel MT; Solary E
Oncogene; 1998 Jun; 16(22):2885-94. PubMed ID: 9671409
[TBL] [Abstract] [Full Text] [Related]
14. Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin.
Bacci G; Ferrari S; Delepine N; Bertoni F; Picci P; Mercuri M; Bacchini P; Brach del Prever A; Tienghi A; Comandone A; Campanacci M
J Clin Oncol; 1998 Feb; 16(2):658-63. PubMed ID: 9469355
[TBL] [Abstract] [Full Text] [Related]
15. Independent expression of p55 and p75 interleukin-2 receptors (IL-2R) during intravenous or subcutaneous administration of recombinant interleukin-2 (rIL-2) by T-lymphocytes and natural killer cells.
Zambello R; Trentin L; Cerutti A; Enthammer C; Milani A; Franceschi T; Messina C; Cetto GL; Agostini C; Semenzato G
Cancer; 1994 Nov; 74(9):2562-9. PubMed ID: 7522954
[TBL] [Abstract] [Full Text] [Related]
16. Increased survival, limb preservation, and prognostic factors for osteosarcoma.
Petrilli AS; Gentil FC; Epelman S; Lopes LF; Bianchi A; Lopes A; Figueiredo MT; Marques E; De Bellis N; Consentino E
Cancer; 1991 Aug; 68(4):733-7. PubMed ID: 1855172
[TBL] [Abstract] [Full Text] [Related]
17. Pathologic fracture in osteosarcoma. Impact of chemotherapy on primary tumor and survival.
Jaffe N; Spears R; Eftekhari F; Robertson R; Cangir A; Takaue Y; Carrasco H; Wallace S; Ayala A; Raymond K
Cancer; 1987 Feb; 59(4):701-9. PubMed ID: 3492261
[TBL] [Abstract] [Full Text] [Related]
18. Control of primary osteosarcoma with chemotherapy.
Jaffe N; Robertson R; Takaue Y; Cangir A; Wallace S; Carrasco H; Eftekhari F; Ayala A; Wang A
Cancer; 1985 Aug; 56(3):461-6. PubMed ID: 3873985
[TBL] [Abstract] [Full Text] [Related]
19. Computed tomography of osteosarcoma after intraarterial chemotherapy.
Shirkhoda A; Jaffe N; Wallace S; Ayala A; Lindell MM; Zornoza J
AJR Am J Roentgenol; 1985 Jan; 144(1):95-9. PubMed ID: 3871155
[TBL] [Abstract] [Full Text] [Related]
